Latest Breaking News On - Treatment failure favored filgotinib - Page 1 : comparemela.com

Phase 2 data on filgotinib show a reduction in risk of flare in patients with uveitis and good tolerance in one of the first studies of a JAK inhibitor in uveitis.

United kingdomRobin besuyenFilgotinib jyselecaXenofon baraliakosGilead sciencesEuropean unionDrug administrationRuhr university bochum germanyInternational congress on spondyloarthritidesInternational congressRuhr university bochumDouble blind trialVery fewTreatment failure favored filgotinibIntraocular inflammationRheumatoid arthritis